Price
Target price
€9.50
€9.50
2.150%
0.2
2.150%
-
18.09.24 / Stuttgart Stock Exchange
WKN: A2DG49 / Name: KalVista / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Carbylan Therapeutics Inc Stock
There is an upward development for Carbylan Therapeutics Inc compared to yesterday, with an increase of €0.20 (2.150%).
So far the community has only identified positive things for Carbylan Therapeutics Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Carbylan Therapeutics Inc in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Carbylan Therapeutics Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Carbylan Therapeutics Inc | 2.150% | -2.062% | -17.391% | 3.825% | -12.844% | -40.994% | -26.277% |
Syros Pharmaceuticals Inc. | -5.560% | 33.333% | 29.496% | -50.139% | -72.727% | -95.833% | - |
Clinuvel Pharmaceuticals | 0.670% | 2.036% | 6.746% | -6.953% | -7.903% | -64.121% | -44.832% |
Pharma Mar S.A. | 1.590% | 1.342% | 17.575% | 25.015% | -0.283% | -46.481% | 85.536% |